95 related articles for article (PubMed ID: 9570353)
1. Cancer cells isolated from malignant pleural and peritoneal effusions inhibit phospholipase A2 activity in human polymorphonuclear leukocytes.
Abe M; Kitsuki H; Saruwatari S; Asoh H; Sakurada T; Kuwata H; Nakatani Y; Kudo I; Furukawa T
Cancer Lett; 1997 Dec; 121(2):155-61. PubMed ID: 9570353
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
Bauldry SA; Wooten RE
Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
Bauldry SA; McCall CE; Cousart SL; Bass DA
J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897
[TBL] [Abstract][Full Text] [Related]
5. Adenosine. An endogenous inhibitor of arachidonic acid release and leukotriene biosynthesis in human neutrophils.
Krump E; Borgeat P
Adv Exp Med Biol; 1999; 447():107-15. PubMed ID: 10086187
[TBL] [Abstract][Full Text] [Related]
6. PAF and LTB4 biosynthesis in the human neutrophil: effects of putative inhibitors of phospholipase A2 and specific inhibitors of 5-lipoxygenase.
Glaser KB; Lock YW; Chang JY
Agents Actions; 1991 Sep; 34(1-2):89-92. PubMed ID: 1665306
[TBL] [Abstract][Full Text] [Related]
7. Influence of arachidonic acid on indices of phospholipase A2 activity in the human neutrophil.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):825-31. PubMed ID: 8387780
[TBL] [Abstract][Full Text] [Related]
8. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
Villani-Price D; Yang DC; Walsh RE; Fretland DJ; Keith RH; Kocan G; Kachur JF; Gaginella TS; Tsai BS
J Pharmacol Exp Ther; 1992 Jan; 260(1):187-91. PubMed ID: 1309871
[TBL] [Abstract][Full Text] [Related]
9. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
Williams JD; Lee TH; Lewis RA; Austen F
J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
[TBL] [Abstract][Full Text] [Related]
10. Effects of a 5-lipoxygenase inhibitor, AA861, on lipoxygenase metabolism and superoxide anion generation by human polymorphonuclear leukocytes--potentiation of superoxide anion generation by LTB4.
Tanaka K; Abe M; Shigematsu N
Int Arch Allergy Immunol; 1992; 98(4):361-9. PubMed ID: 1330136
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene B4 generation by human monocytes and neutrophils stimulated by uropathogenic strains of Escherichia coli.
Steadman R; Topley N; Knowlden J; Spur B; Williams J
Biochim Biophys Acta; 1990 May; 1052(2):264-72. PubMed ID: 2159346
[TBL] [Abstract][Full Text] [Related]
12. Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85-kD cytosolic phospholipase A2.
Doerfler ME; Weiss J; Clark JD; Elsbach P
J Clin Invest; 1994 Apr; 93(4):1583-91. PubMed ID: 7512985
[TBL] [Abstract][Full Text] [Related]
13. Group IB secretory phospholipase A2 stimulates leukotriene B4 production by a unique mechanism in human neutrophils.
Lee HY; Kim MK; Park KS; Shin EH; Bae YS
Biochem Biophys Res Commun; 2005 Aug; 334(2):500-8. PubMed ID: 16005851
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils.
Surette ME; Dallaire N; Jean N; Picard S; Borgeat P
FASEB J; 1998 Nov; 12(14):1521-31. PubMed ID: 9806761
[TBL] [Abstract][Full Text] [Related]
15. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
[TBL] [Abstract][Full Text] [Related]
16. Enhanced generation of leukotriene B4 by neutrophils stimulated by unopsonized zymosan and by calcium ionophore after exercise-induced asthma.
Arm JP; Horton CE; House F; Clark TJ; Spur BW; Lee TH
Am Rev Respir Dis; 1988 Jul; 138(1):47-53. PubMed ID: 2849339
[TBL] [Abstract][Full Text] [Related]
17. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes.
Goldman DW; Goetzl EJ
J Immunol; 1982 Oct; 129(4):1600-4. PubMed ID: 6286770
[TBL] [Abstract][Full Text] [Related]
18. Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation.
Clancy RM; Dahinden CA; Hugli TE
Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7200-4. PubMed ID: 6417666
[TBL] [Abstract][Full Text] [Related]
19. Interaction of human neutrophils with airway epithelial cells: reduction of leukotriene B4 generation by epithelial cell derived prostaglandin E2.
Klockmann MT; Jahn HU; Hippenstiel S; Krämer HJ; Suttorp N
J Cell Physiol; 1998 Jun; 175(3):268-75. PubMed ID: 9572471
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase A2 as leukotriene B4 secretagogue for human polymorphonuclear leukocytes.
Lam BK; Yang CY; Wong PY
Adv Exp Med Biol; 1990; 275():183-91. PubMed ID: 2173367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
